Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) Current Assets (2013 - 2026)

Updated

Coherus Oncology (CHRS) recorded Current Assets of $133.79 million in Q2 2026, down 64.8% from $380.21 million a year earlier and down 35.1% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Coherus Oncology reported Current Assets of $206.71 million, down 39.5% from FY2024.

  • Annual Current Assets has a five-year compound annual growth rate of -23.1% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $341.58 million in FY2024 (-28.2%), $475.63 million in FY2023 (+24.8%), $381.23 million in FY2022 (-36.7%) and $602.32 million in FY2021 (-21.5%).
  • The Q2 2026 figure is the lowest quarterly Current Assets since Q4 2018.
  • On a year-over-year basis, Current Assets has declined for three consecutive quarters, with an average decline of 30.1% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 98.6% in Q1 2024, against a decline of 64.8% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $206.04 million (Q1 2026), $206.71 million (Q4 2025) and $460.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 59.77 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 33.67 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 27.97 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 13.95 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 41.36 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn 133.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 133.79 Mn
Mar 31, 2026 206.04 Mn
Dec 31, 2025 206.71 Mn
Sep 30, 2025 460.96 Mn
Jun 30, 2025 380.21 Mn
Mar 31, 2025 310.18 Mn
Dec 31, 2024 341.58 Mn
Sep 30, 2024 369.02 Mn
Jun 30, 2024 557.93 Mn
Mar 31, 2024 627.48 Mn
Dec 31, 2023 475.63 Mn
Sep 30, 2023 444.37 Mn
Jun 30, 2023 385.48 Mn
Mar 31, 2023 315.93 Mn
Dec 31, 2022 381.23 Mn
Sep 30, 2022 448.28 Mn
Jun 30, 2022 446.78 Mn
Mar 31, 2022 512.44 Mn
Dec 31, 2021 602.32 Mn
Sep 30, 2021 673.04 Mn
API Access

Coherus Oncology Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=CHRS&period=max&api_key=YOUR_API_KEY